1. 1487PLURET: Final survival results of the phase II trial of vandetanib in patients with advanced RET-rearranged non-small cell lung cancer. (23rd October 2018) Authors: Yoh, K; Seto, T; Satouchi, M; Nishio, M; Yamamoto, N; Murakami, H; Nogami, N; Kuroda, S; Nomura, S; Sato, A; Tsuchihara, K; Kohno, T; Matsumoto, S; Goto, K Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 1399PImpact of lorlatinib on patient-reported outcomes (PROs) in patients (Pts) with advanced ALK+ or ROS1+ non-small cell lung cancer (NSCLC). (23rd October 2018) Authors: Peters, S; Shaw, A T; Besse, B; Felip, E; Solomon, B J; Soo, R A; Bearz, A; Gadgee, S M; Lin, C-C; Kao, S; Seto, T; Masters, E T; Abbattista, A; Clancy, J S; Thurm, H; Reisman, A; Camidge, D R Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. LBA4Efficacy and safety of entrectinib in patients with NTRK fusion-positive tumours: Pooled analysis of STARTRK-2, STARTRK-1, and ALKA-372-001. (25th November 2018) Authors: Demetri, G D; Paz-Ares, L; Farago, A F; Liu, S V; Chawla, S P; Tosi, D; Kim, E S; Blakely, C M; Krauss, J C; Sigal, D; Bazhenova, L; John, T; Besse, B; Wolf, J; Seto, T; Chow-Maneval, E; Multani, P S; Johnson, A; Simmons, B; Doebele, R C Journal: Annals of oncology Issue: Volume 29(2018)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. LBA61Phase II results for single-agent nazartinib (EGF816) in adult patients (pts) with treatment-naive EGFR-mutant non-small cell lung cancer (NSCLC). (23rd October 2018) Authors: Tan, D S; Kim, S-W; Sequist, L V; Ponce Aix, S; Smit, E F; Hida, T; Yang, J C-H; Felip, E; Seto, T; Grohe, C; Wolf, J; Ko, J; Marriere, E; Belli, R; Giovannini, M; Kim, D-W Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. "Just Like Me": A Culturally-Relevant Narrative Video Intervention for Heart Failure Management. (21st November 2018) Authors: Sentell, T; Kennedy, F; Seto, T; Vawer, M; Valdez, C; Garrett, L; Paloma, D; Taira, D Journal: European journal of public health Issue: Volume 28(2018)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. If he wasn't helping me, I'd be dead: Social Networks of Patients with Preventable Hospitalizations. (21st November 2018) Authors: Sentell, T; Davis, J; Mannem, S; Seto, T; Kennedy, F; Vawer, M; Taria, D Journal: European journal of public health Issue: Volume 28(2018)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. LBA18Survival and treatment patterns in patients (pts) with locally advanced or metastatic NSCLC treated with epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIS): Analysis of US insurance claims databases. (24th November 2019) Authors: Soo, R; Seto, T; Gray, J E; Karimi, P; Taylor, A; Sawyer, W; Thiel, E; Marchlewicz, E; Brouillette, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Final overall survival results of WJTOG3405, a randomized phase III trial comparing gefitinib versus cisplatin with docetaxel as the first-line treatment for patients with stage IIIB/IV or postoperative recurrent EGFR mutation-positive non-small-cell lung cancer. (25th September 2019) Authors: Yoshioka, H; Shimokawa, M; Seto, T; Morita, S; Yatabe, Y; Okamoto, I; Tsurutani, J; Satouchi, M; Hirashima, T; Atagi, S; Shibata, K; Saito, H; Toyooka, S; Yamamoto, N; Nakagawa, K; Mitsudomi, T Journal: Annals of oncology Issue: Volume 30:Number 12(2019) Page Start: 1978 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. 1741PDRandomized phase II trial of CODE or AP after chemoradiotherapy for LD-SCLC: Long-term survival and toxicity analysis. (1st October 2019) Authors: Sekine, ; Harada, H; Yamamoto, N; Wakabayashi, M; Murakami, H; Goto, K; Nogami, N; Seto, T; Oshita, F; Okamoto, H; Tanaka, H; Tamura, T; Ishikura, S; Ohe, Y Journal: Annals of oncology Issue: Volume 30(2019)Supplement 5 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Effects of exposure to microwaves on cellular immunity and placental steroids in pregnant rats. Issue 9 (September 1997) Authors: Nakamura, H; Seto, T; Nagase, H; Yoshida, M; Dan, S; Ogino, K Journal: Occupational and environmental medicine Issue: Volume 54:Issue 9(1997) Page Start: 676 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗